| Literature DB >> 26869056 |
Soumana C Nasser1, Aline Hanna Saad2, Lamis R Karaoui3.
Abstract
BACKGROUND: This study aims to map the learned curriculum based on students' feedback regarding the biomedical literature evaluation competencies in a pharmacy curriculum, to evaluate teaching methods and to report students' longitudinal self-assessment of their achievement of related learning outcomes as they progress from didactic to experiential courses.Entities:
Mesh:
Year: 2016 PMID: 26869056 PMCID: PMC4751754 DOI: 10.1186/s12909-016-0583-7
Source DB: PubMed Journal: BMC Med Educ ISSN: 1472-6920 Impact factor: 2.463
Students’ mapping of biomedical literature evaluation skills-achieving similar learning outcomes in PHA 421, 557 and 570. (percentages for answering either ‘agree’ or ‘strongly agree’)
| (At the end of each course, the student strongly agrees or agrees that the below SLOs are met) | PHA 421 | PHA 557 | PHA 570 |
|---|---|---|---|
| ( | ( | ( | |
| Identify and conduct a literature search using search engines (PEa database, secondary resources, PubMed, etc.) | 56 (82 %) | 63 (88 %) | 34 (90 %) |
| Describe different study designs and characteristics (i.e. experimental vs. non experimental designs, different PE models, clinical trials) | 57 (84 %) | 58 (80 %) | 37 (97 %) |
| Define and interpret statistical parameters (i.e. study validity and reliability, power, | 55 (81 %) | 66 (92 %) | 37 (97 %) |
| Critically evaluate clinical and/or PE studies (i.e. determine the study internal/external validities, apply PE in pharmaceutical care decisions making) | 61 (90 %) | 58 (80 %) | 36 (95 %) |
aPE: Pharmacoeconomics
Students’ mapping of the biomedical literature evaluation skills – evaluating the delivery methods in PHA 421, 557 and 570. (percentages for answering either ‘agree’ or ‘strongly agree’)
| PHA421 | PHA557 | PHA570 | |
|---|---|---|---|
| In-Class Team-Work Learning Activities: | |||
| Number of class hours spend preparing me to critically analyze PEa/clinical trials were adequate | 23 (34 %) | 58 (81 %) | -- |
| In-class learning activities (on assignments) facilitated my learning of class materials | 54 (80 %) | 57 (79 %) | -- |
| In-class learning activities helped me improve my progress in analyzing PE/clinical trials | 53 (78 %) | 66 (92 %) | -- |
| In-class discussing articles in a small group setting helped reinforce course materials more than studying alone | 55 (81 %) | 64 (89 %) | -- |
| In-class discussing articles increased my confidence in my knowledge for evaluating PE/clinical trials | 59 (86 %) | 66 (92 %) | -- |
| Outside Class in Addition to In-Class Team-Work Learning Activities: | |||
| In/out-side class team-work on assignments/article analysis increased my confidence in knowing how to analyze clinical/PE articles | 45 (66 %) | 61 (85 %) | 34 (89 %) |
| In/out-side class team-work discussing/presenting article as presentation helped reinforce my ability to evaluate articles | 49 (72 %) | 61 (85 %) | 34 (89 %) |
| In/out-side class team-work applying course materials on projects/assignments provided a less stressful learning environment | 49 (72 %) | 67 (93 %) | 31 (83 %) |
| In/out-side class learning activities on assignments ‘in didactic courses’/working in the Library ‘in the experiential course’ were a waste of class time | 3 (5 %) | 4 (6 %) | 18 (48 %) |
aPE: Pharmacoeconomics
Students’ longitudinal self-assessment of their readiness to evaluate the biomedical literature: clinical trials in PHA421/PHA570, and pharmacoeconomic (PE) trials in PHA557: (percentages for answering either ‘agree’ or ‘strongly agree’)
| PHA421 | PHA557 | PHA570 |
| |
|---|---|---|---|---|
| Prior to the BEGINNING of this course: | ||||
| I already knew how to differentiate among different types of clinical/PEa study designs. | 5 (8 %) | 8 (11 %) | 25 (67 %) | <0.001 |
| I already knew how to evaluate clinical/PE trials | 6 (9 %) | 5 (7 %) | 16 (42 %) | <0.001 |
| By the END of this course: | ||||
| I know how to determine the external validity of a PE/clinical trial | 44 (65 %) | 61 (85 %) | 34 (89 %) | 0.003 |
| My perception on critically evaluating a PE/clinical trial significantly improved | 49 (72 %) | 69 (96 %) | 35 (92 %) | <0.001 |
|
| <0.001 | <0.001 | <0.001 | |
aPE: Pharmacoeconomics
Direct and indirect assessment of certain course specific learning outcomes related to biomedical literature evaluation covered in the final exam of each course
| Direct assessment | Indirect assessment | |
|---|---|---|
| PHA421, | N (%) | N (%) |
| Evaluate clinical trials published in the medical and pharmaceutical literature | 63 (92 %) | 61 (90 %) |
| Describe different study designs including experimental and non-experimental designs. | 60 (88 %) | 57 (84 %) |
| Interpret study statistical analysis including | 55 (81 %) | 55 (81 %) |
| PHA557, | ||
| Critically evaluate a pharmacoeconomic article (i.e. apply PEa in pharmaceutical care decisions making) | 53 (74 %) | 58 (80 %) |
| Define type I error, Type II error, power, effect size, | 66 (92 %) | 66 (92 %) |
| PHA570, | ||
| Critically evaluate clinical trials (e.g. identify study characteristics, interpret the statistical data, and determine the study internal and external validities) | 33 (87 %) | 37 (97 %) |
aPE: Pharmacoeconomics